Principal Financial Group’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $123K | Sell |
|
|||||
|
2022
Q2 | $460K | Sell |
|
|||||
|
2022
Q1 | $614K | Sell |
|
|||||
|
2021
Q4 | $1.19M | Sell |
|
|||||
|
2021
Q3 | $3.06M | Buy |
|
|||||
|
2021
Q2 | $3.8M | Buy |
|
|||||
|
2021
Q1 | $2.21M | Buy |
|
|||||
|
2020
Q4 | $1.42M | Sell |
|
|||||
|
2020
Q3 | $2.67M | Buy |
|
|||||
|
2020
Q2 | $1.73M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $305K | Sell |
|
|||||
|
2019
Q2 | $1.26M | Sell |
|
|||||
|
2019
Q1 | $2.11M | Buy |
|
|||||
|
2018
Q4 | $1.43M | Sell |
|
|||||
|
2018
Q3 | $2.62M | Sell |
|
|||||
|
2018
Q2 | $4.11M | Buy |
|
|||||
|
2018
Q1 | $3.4M | Sell |
|
|||||
|
2017
Q4 | $4.38M | Buy |
|
|||||
|
2017
Q3 | $3.85M | Sell |
|
|||||
|
2017
Q2 | $4.44M | Buy |
|
|||||
|
2017
Q1 | $434K | Buy |
|
|||||
|
2016
Q4 | $262K | Buy |
|
|||||
|
2016
Q3 | $202K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $4.99M | Sell |
|
|||||
|
2015
Q2 | $4.96M | Buy |
|
|||||
|
2015
Q1 | $4.16M | Buy |
|
|||||
|
2014
Q4 | $3.12M | Sell |
|
|||||
|
2014
Q3 | $2.53M | Sell |
|
|||||
|
2014
Q2 | $2.32M | Buy |
|
|||||
|
2014
Q1 | $3.87M | Buy |
|
|||||
|
2013
Q4 | $3.35M | Buy |
|
|||||
|
2013
Q3 | $2.93M | Buy |
|
|||||
|
2013
Q2 | $2.77M | Buy |
|